Table 6 Clinical pathology in both treatment groups
From: A highly efficacious pediculicide based on dimeticone: Randomized observer blinded comparative trial
Dimeticone group n (%) | Permethrin group n (%) | P value | |
|---|---|---|---|
Cervical lymphadenopathy: | |||
Before treatment | 49/73 (67.1%) | 54/72 (75.0%) | P = 0.3 |
Day 2 | 51/73 (69.9%) | 52/72 (72.2%) | P = 0.8 |
Day 4 | 52/73 (71.2%) | 49/72 (68.1%) | P = 0.7 |
Day 7 | 39/73 (53.4%) | 46/72 (63.9%) | P = 0.2 |
Day 9 | 41/72 (56.9%) | 45/71 (63.4%) | P = 0.7 |
Bacterial superinfection of lesions: | |||
Before treatment | 1/73 (1.4%) | 0/72 (0%) | P = 0.3 |
Day 2 | 1/73 (1.4%) | 1/72 (1.4%) | P = 1.0 |
Day 4 | 1/73 (1.4%) | 0/72 (0%) | P = 0.3 |
Day 7 | 0/73 (0%) | 0/72 (0%) | P = 1.0 |
Day 9 | 0/72 (0%) | 0/71 (0%) | P = 1.0 |